Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
Mizutani Y, Kawamoto S, Takahashi M, Doi H, Wakida K, Tabuchi S, Tanda M, Soga A, Chijiki R, Takakura H, Kawaguchi K, Higashime A, Watanabe M, Ichikawa H, Matsumoto S, Sakai R, Goto H, Kurata K, Kakiuchi S, Miyata Y, Uryu K, Inui Y, Kitao A, Yakushijin K, Matsuoka H, Minami H. Mizutani Y, et al. Among authors: miyata y. Intern Med. 2023 Oct 15;62(20):2949-2958. doi: 10.2169/internalmedicine.1314-22. Epub 2023 Feb 15. Intern Med. 2023. PMID: 36792187 Free PMC article. Clinical Trial.
Tolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation.
Yakushijin K, Yamamoto K, Kurata K, Miyata Y, Kakiuchi S, Tomioka H, Kawamori-Iwamoto Y, Inui Y, Sanada Y, Okamura A, Murayama T, Matsuoka H, Minami H. Yakushijin K, et al. Among authors: miyata y. Int J Hematol. 2013 Feb;97(2):284-6. doi: 10.1007/s12185-012-1248-x. Epub 2013 Jan 8. Int J Hematol. 2013. PMID: 23297121
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen.
Miyata Y, Yakushijin K, Inui Y, Imamura Y, Goto H, Mizutani Y, Kurata K, Kakiuchi S, Sanada Y, Minami Y, Kawamoto S, Yamamoto K, Ito M, Tominaga R, Gomyo H, Mizuno I, Nomura T, Kitagawa K, Sugimoto T, Murayama T, Matsuoka H, Minami H. Miyata Y, et al. Int J Hematol. 2016 Dec;104(6):682-691. doi: 10.1007/s12185-016-2089-9. Epub 2016 Sep 9. Int J Hematol. 2016. PMID: 27612464 Clinical Trial.
A Case of Classical Hodgkin Lymphoma with Total Lymph Node Infarction.
Okuni M, Yakushijin K, Sakai Y, Suto H, Ichikawa H, Sakai R, Kakiuchi S, Kurata K, Mizutani Y, Kitao A, Miyata Y, Saito Y, Kawamoto S, Yamamoto K, Ito M, Matsuoka H, Minami H. Okuni M, et al. Among authors: miyata y. J Clin Exp Hematop. 2018 Mar 16;58(1):24-26. doi: 10.3960/jslrt.17026. Epub 2018 Feb 8. J Clin Exp Hematop. 2018. PMID: 29415974 Free PMC article.
Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients.
Kurata K, Yakushijin K, Okamura A, Yamamori M, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Kawamoto S, Matsuoka H, Murayama T, Minami H. Kurata K, et al. Among authors: miyata y. Cancer Chemother Pharmacol. 2018 May;81(5):839-846. doi: 10.1007/s00280-018-3550-7. Epub 2018 Mar 6. Cancer Chemother Pharmacol. 2018. PMID: 29511796
Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese population.
Kurata K, Yakushijin K, Mizuno I, Gomyo H, Okamura A, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Sanada Y, Inui Y, Uryu K, Kawamoto S, Sugimoto T, Yamamoto K, Ito M, Matsuoka H, Murayama T, Minami H. Kurata K, et al. Among authors: miyata y. Int J Hematol. 2018 Jul;108(1):58-65. doi: 10.1007/s12185-018-2437-z. Epub 2018 Mar 22. Int J Hematol. 2018. PMID: 29569120
1,473 results